1800 527 226 call now Important Safety Information
Call Now 1800-527-226
NEED FINANCING? MEDICREDIT CAN HELP.

mediCREDIT Australia has developed a financing option to enable you to pay for your LAP-BAND® System procedure. The programme helps patients pay for out-of-pocket expenses associated with LAP-BAND® System procedures and aftercare from $2,000 to $20,000+ through simple, low-interest installment loans.*

WHY APPLY FOR MEDICREDIT FINANCING?
  • Payment plans
  • Plans up to 84 months to help suit every budget
  • Flexible options – any additional repayments or rebates from Medicare/Private Health can be added back on to the payment plan at no extra charge
  • No stress – the whole process is managed privately by mediCREDIT consultants
  • No upfront fees
  • Fast efficient approvals, simply apply online
Apply now
Want to Talk?

Want to Talk? CALL 1800 527 226

Have a question? Need more information? We’re here to talk you through your options.

Go
What’s Your Body Mass Index?

What’s Your Body Mass Index?

Your body mass index - or “BMI” - is important to know. You can calculate quickly and easily here.

Go
Want to Talk?

Want to Talk? CALL 1800 527 226

Have a question? Need more information? We’re here to talk you through your options.

Go
Important LAP-BAND® System Safety Information

Indications: The LAP-BAND AP® Systems is indicated for use in weight reduction for severely obese patients with a Body Mass Index (BMI) of at least 35 or a BMI of at least 30 with one or more severe comorbid conditions, or those who are 100 pounds or more over their estimated ideal weight according to the 1983 Metropolitan Life Insurance Tables (use the midpoint for medium frame). It is indicated for use only in severely obese patients 14 years and older who have failed more conservative weight-reduction alternatives, such as supervised diet, exercise and behavior modification programs. Patients who elect to have this surgery must make the commitment to accept significant changes in their eating habits for the rest of their lives. Weight loss associated with the LAP-BAND® System has been shown to improve or lead to remission of type 2 diabetes in patients with BMI greater than or equal to 35.

Contraindications: The LAP-BAND® AP System is not recommended for patients under 14, patients with conditions that may make them poor surgical candidates or increase the risk of poor results (e.g., inflammatory or cardiopulmonary diseases, GI conditions, symptoms or family history of autoimmune disease, cirrhosis), who are unwilling or unable to comply with the required dietary restrictions, who have alcohol or drug addictions, or who currently are or may be pregnant.

Warnings: The LAP-BAND® AP System is a long-term implant. Explant and replacement surgery may be required. Patients who become pregnant or severely ill, or who require more extensive nutrition may require deflation of their bands. Anti-inflammatory agents, such as aspirin, should be used with caution and may contribute to an increased risk of band erosion.

Adverse Events: Placement of the LAP-BAND® AP System is major surgery and, as with any surgery, death can occur. Possible complications include the risks associated with the medications and methods used during surgery, the risks associated with any surgical procedure, and the patient’s ability to tolerate a foreign object implanted in the body. Band slippage, erosion and deflation, reflux, obstruction of the stomach, dilatation of the oesophagus, infection, or nausea and vomiting may occur. Reoperation may be required. Rapid weight loss may result in complications that may require additional surgery. Deflation of the band may alleviate excessively rapid weight loss or oesophageal dilatation.

Important: For full safety information please click here, talk with your doctor.


References:
1. O'Brien, Annemarie Hindle, Leah Brennan, Stewart Skinner, Paul Burton, et al. "Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-Analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding." Obesity Surgery. The Journal of Metabolic Surgery and Allied Care. Published online: 06 October 2018. https://doi.org/10.1007/s11695-018-3525-0
2. Data on File: ReShape Lifesciences Inc.

RESHAPE, RESHAPE LIFESCIENCES, LAP-BAND, the ReShape Lifesciences and the LAP-BAND Logos are trademarks of ReShape Lifesciences, Inc.
©2020 ReShape Lifesciences, Inc. All rights reserved. Powered by Sequence Health.